Prevention of infectious complications in peritoneal dialysis: best demonstrated practices

被引:121
作者
Bender, F. H. [1 ]
Bernardini, J. [1 ]
Piraino, B. [1 ]
机构
[1] Univ Pittsburgh, Sch Med, Renal Electrolyte Div, Pittsburgh, PA 15213 USA
关键词
peritoneal dialysis; peritonitis; exit site infection; tunnel infections; prophylaxis; CQI;
D O I
10.1038/sj.ki.5001915
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
Peritoneal dialysis (PD) related infections continue to be a serious complication for PD patients. Peritonitis can be associated with pain, hospitalization and catheter loss as well as a risk of death. Peritonitis risk is not evenly spread across the PD population or programs. Very low rates of peritonitis in a program are possible if close attention is paid to the causes of peritonitis and protocols implemented to reduce the risk of infection. Protocols to decrease infection risk in PD patients include proper catheter placement, exit-site care that includes Staphylococcus aureus prophylaxis, careful training of patients with periodic retraining, treatment of contamination, and prevention of procedure-related and fungal peritonitis. Extensive data have been published on the use of antibiotic prophylaxis to prevent exit site infections. There are fewer data on training methods of patients to prevent infection risk. Quality improvement programs with continuous monitoring of infections, both of the catheter exit site and peritonitis, are important to decrease the PD related infections in PD programs. Continuous review of every episode of infection to determine the root cause of the event should be routine in PD programs. Further research is needed examining approaches to decrease infection risk.
引用
收藏
页码:S44 / S54
页数:11
相关论文
共 120 条
[1]  
ABRAHAM G, 1988, PERITON DIALYSIS INT, V8, P211
[2]   The spectrum of infection-related morbidity in hospitalized haemodialysis patients [J].
Allon, M ;
Radeva, M ;
Bailey, J ;
Beddhu, S ;
Butterly, D ;
Coyne, DW ;
Depner, TA ;
Gassman, JJ ;
Kaufman, AM ;
Kaysen, GA ;
Lewis, JA ;
Schwab, SJ .
NEPHROLOGY DIALYSIS TRANSPLANTATION, 2005, 20 (06) :1180-1186
[3]  
Annigeri R, 2001, PERITON DIALYSIS INT, V21, P554
[4]  
[Anonymous], 1988, ADV PERIT DIAL
[5]  
ASLAM N, 2005, J AM SOC NEPHROL, V16, pA296
[6]  
Bending M, 1996, J AM SOC NEPHROL, V7, P2403
[7]   A randomized trial of Staphylococcus aureus prophylaxis in peritoneal dialysis patients: Mupirocin calcium ointment 2% applied to the exit site versus cyclic oral rifampin [J].
Bernardini, J ;
Piraino, B ;
Holley, J ;
Johnston, JR ;
Lutes, R .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1996, 27 (05) :695-700
[8]   Randomized, double-blind trial of antibiotic exit site cream for prevention of exit site infection in peritoneal dialysis patients [J].
Bernardini, J ;
Bender, F ;
Florio, T ;
Sloand, J ;
PalmMontalbano, L ;
Fried, L ;
Piraino, B .
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (02) :539-545
[9]   ANALYSIS OF CONTINUOUS AMBULATORY PERITONEAL DIALYSIS-RELATED PSEUDOMONAS-AERUGINOSA INFECTIONS [J].
BERNARDINI, J ;
PIRAINO, B ;
SORKIN, M .
AMERICAN JOURNAL OF MEDICINE, 1987, 83 (05) :829-832
[10]  
BERNARDINI J, IN PRESS PERIT DIAL